Topnav

Tag Archives | BHF

Bonitas recognised for service

At the 17th annual Board of Healthcare Funders conference held in Cape Town, Bonitas Medical Fund (Bonitas) was awarded the ‘Service to membership – Open Medical Schemes’ Titanium Award, which benchmarks excellence in the industry. The aim of the Awards is to the improve the quality of health services, create a platform that unites the […]

Continue Reading · 0

A win for dispensing doctors

Dispensing doctors have won the last of their battles to effectively nullify most of the requirements around dispensing licences in the much-contested regulations of the Medicines and Related Substances Act that came into effect in 2003. From this year, doctors with valid dispensing licences will no longer be obliged to renew them once obtained and […]

Continue Reading · 0

Market inquiry supported

Stakeholders in the private healthcare sector have reacted positively to the terms of reference (TOR) for the Competition Commission’s (CC) market inquiry in the industry, expressing hope that the investigation would be thorough enough to reveal the true nature of private healthcare costs and lay to rest the many misconceptions and myths around it. Describing […]

Continue Reading · 0

Scheme rules: It’s war

Some specialists are drawing the battle lines in a fight to reclaim their right to put their patients before formularies, rules and restrictions imposed on them by medical schemes. In an open letter published in the March/April edition of The South African Gastroenterology Review journal, specialist surgeon and gastroenterologist, Dr Stephen Grobler, addressed medical industry roleplayers […]

Continue Reading · 0

Fraud or feigned hysteria?

Dr Tony Behrman, COO, IPAF  We heard recently from reports at the Board of Healthcare Funders’ (BHF) Healthcare Fraud Investigators workshop that the healthcare industry is reeling under the burden of fraud to an annual amount of R22bn, or 21% of the entire payout by medical schemes to all suppliers of service including hospitals, managed care companies, […]

Continue Reading · 0

Law in Practice: Competition Commission inquiry: what’s it about?

Elsabé Klink With the publication of the bringing into effect of amendments to the Competition Act, the stage seems to be set for the private healthcare sector market inquiry. The terms of reference of the inquiry is not known yet and would be published prior to the commencement of the inquiry. Stakeholders would then have […]

Continue Reading · 0

Docs will benefit if funders stand together to fight fraud

While most medical schemes go to great pains to emphasise that it is only the few ‘bad eggs’ among service providers that commit fraud against funders, the public image of medical professionals continues to bear the brunt of this scourge. And medical schemes may be contributing to the problem by adopting a ‘lone-rider’ approach to […]

Continue Reading · 0

Medical Schemes Should Plan Properly to Address Rising Demand for Biologics

Increased demand for biologics will only seriously impact medical schemes if they don’t plan properly, and society fails to make a decision on how to approach the difficult subject of how to measure a quality-adjusted life year (QALY), or the value for money of medical interventions. Dr Jonathan Broomberg, Discovery Health CEO, recently projected that by […]

Continue Reading · 0

The Tariff Tango: Led by an Ideology Clash?

The six-year long dance routine in developing an accepted tariff list for private medical practitioners may have as much to do with a clash of ideologies as with a disagreement on what is a ‘fair price’. This is the view of Dr Chris Archer, CEO of the SA Private Practitioners Forum (SAPPF). He was reflecting the […]

Continue Reading · 0